Description

Carbamic Acid, (4-(2-Hydroxy-3-((1-Methylethyl)Amino)Propoxy)Phenyl)-, Ethyl Ester, Monohydrochloride is a high-purity, synthetically derived organic compound primarily utilized as a key pharmaceutical intermediate. Its molecular structure, featuring a carbamate ester and a phenoxypropanolamine moiety, makes it a critical building block in the synthesis of advanced active pharmaceutical ingredients (APIs). This compound is essential for manufacturers in the life sciences sector requiring reliable, high-quality intermediates for cardiovascular and β-blocker research and production.

Application

• Pharmaceutical Intermediate: A crucial precursor in the multi-step synthesis of β-adrenergic blocking agents (β-blockers).
• API Synthesis: Used in the research and development of novel cardiovascular and antihypertensive drugs.
• Chemical Research: Serves as a specialized building block in medicinal chemistry for structure-activity relationship (SAR) studies.
• Process Development: Employed in scaling up and optimizing manufacturing routes for target pharmaceutical molecules.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control in pharmaceutical labs.

Basic Information

Product Name	Carbamic Acid, (4-(2-Hydroxy-3-((1-Methylethyl)Amino)Propoxy)Phenyl)-, Ethyl Ester, Monohydrochloride
CAS No.	83855-51-0
Molecular Formula	C15H24N2O4 • HCl
Molecular Weight	332.82 g/mol (as hydrochloride salt)
Synonyms	Ethyl 4-[2-Hydroxy-3-(isopropylamino)propoxy]phenylcarbamate Hydrochloride; Carvedilol Impurity; Carvedilol Related Compound; 4-[2-Hydroxy-3-[(1-Methylethyl)amino]propoxy]benzenamine Ethyl Carbamate Hydrochloride; UNII-6T5W9F3J8R; Carbamic acid, [4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, ethyl ester, hydrochloride (1:1); Carvedilol Carbamate Ester Hydrochloride
EINECS	Contact for details

Quality Control

Our Carbamic Acid, (4-(2-Hydroxy-3-((1-Methylethyl)Amino)Propoxy)Phenyl)-, Ethyl Ester, Monohydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards for pharmaceutical intermediate use. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.